SLC26A9 and cystic fibrosis: Recently, SNPs in the SLC26A9 gene were found to be associated with CF-related disease onset, suggesting that SLC26A9 acts as a CFTR regulator [202], and may be involved in the response to CFTR-directed therapeutics [172,203].